steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
![Steris logo](/files/LOGO/1757898-STE.png)
Company profile
Ticker
STE
Exchange
Website
CEO
Walter Rosebrough
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
STERIS Ltd
SEC CIK
Corporate docs
Subsidiaries
1666 E Touhy LLC • Accelera Technologies, LLC • Accutron, Inc. • Albert Browne Limited • American Sterilizer Company • Birkova Products, LLC • Bizworth Gammarad Sdn Bhd • Black Diamond Video, Inc. • Camark S.A. • Cantel (Belgium) BV ...
STE stock data
Latest filings (excl ownership)
ARS
2024 FY
Annual report to shareholders
12 Jun 24
DEFA14A
Additional proxy soliciting materials
12 Jun 24
DEF 14A
Definitive proxy
12 Jun 24
SD
Conflict minerals disclosure
31 May 24
8-K
Regulation FD Disclosure
31 May 24
10-K
2024 FY
Annual report
29 May 24
8-K
STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year
8 May 24
8-K
Entry into a Material Definitive Agreement
11 Apr 24
10-Q
2024 Q3
Quarterly report
8 Feb 24
8-K
STERIS Announces Financial Results for Fiscal 2024 Third Quarter
7 Feb 24
Transcripts
STE
Earnings call transcript
2024 Q4
9 May 24
STE
Earnings call transcript
2024 Q3
8 Feb 24
STE
Earnings call transcript
2024 Q2
8 Nov 23
STE
Earnings call transcript
2024 Q1
2 Aug 23
STE
Earnings call transcript
2024 Q1
2 Aug 23
STE
Earnings call transcript
2023 Q4
11 May 23
STE
Earnings call transcript
2023 Q3
9 Feb 23
STE
Earnings call transcript
2023 Q2
10 Nov 22
STE
Earnings call transcript
2023 Q1
3 Aug 22
STE
Earnings call transcript
2022 Q4
12 May 22
Latest ownership filings
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 207.02 mm | 207.02 mm | 207.02 mm | 207.02 mm | 207.02 mm | 207.02 mm |
Cash burn (monthly) | (no burn) | 111.42 k | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 430.79 k | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 206.59 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 1854.2 | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2024
94.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 690 |
Opened positions | 184 |
Closed positions | 58 |
Increased positions | 224 |
Reduced positions | 175 |
13F shares | Current |
---|---|
Total value | 19.67 tn |
Total shares | 93.26 mm |
Total puts | 15.70 k |
Total calls | 62.30 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 11.84 mm | $2.66 tn |
BLK Blackrock | 9.83 mm | $2.21 tn |
Massachusetts Financial Services | 5.66 mm | $1.27 tn |
WCM Investment Management | 4.74 mm | $1.07 tn |
STT State Street | 4.12 mm | $925.84 bn |
MS Morgan Stanley | 3.89 mm | $873.53 bn |
APG Asset Management | 3.73 mm | $777.04 bn |
Geode Capital Management | 2.25 mm | $503.88 bn |
Generation Investment Management | 2.14 mm | $481.29 bn |
JHG Janus Henderson | 2.00 mm | $449.91 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jun 24 | Majors Cary L | Ordinary Shares | Sell | Dispose S | No | No | 229.63 | 4,932 | 1.13 mm | 13,054 |
5 Jun 24 | Majors Cary L | Ordinary Shares | Option exercise | Acquire M | No | No | 114.22 | 4,932 | 563.33 k | 17,986 |
5 Jun 24 | Majors Cary L | Employee Stock Option Ordinary Shares | Option exercise | Dispose M | No | No | 114.22 | 4,932 | 563.33 k | 0 |
5 Jun 24 | Julia Madsen | Ordinary Shares | Sell | Dispose S | No | No | 230 | 3,252 | 747.96 k | 9,671 |
5 Jun 24 | Julia Madsen | Ordinary Shares | Option exercise | Acquire M | No | No | 77.07 | 3,252 | 250.63 k | 12,923 |
5 Jun 24 | Julia Madsen | Ordinary Shares | Sell | Dispose S | No | No | 230 | 400 | 92.00 k | 9,671 |
5 Jun 24 | Julia Madsen | Ordinary Shares | Option exercise | Acquire M | No | No | 69.72 | 400 | 27.89 k | 10,071 |
5 Jun 24 | Julia Madsen | Employee Stock Option Ordinary Shares | Option exercise | Dispose M | No | No | 77.07 | 3,252 | 250.63 k | 0 |
5 Jun 24 | Julia Madsen | Employee Stock Option Ordinary Shares | Option exercise | Dispose M | No | No | 69.72 | 400 | 27.89 k | 0 |
4 Jun 24 | Mary Clare Fraser | Ordinary Shares | Grant | Acquire A | No | No | 0 | 2,040 | 0.00 | 11,132 |
News
JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
26 Jul 24
Here's How STERIS is Placed Ahead of Q1 Earnings
23 Jul 24
These 10 Large Cap Stocks Shined Brightest Last Week (May 5-May 11, 2024): Are They In Your Portfolio?
12 May 24
Piper Sandler Reiterates Neutral on Steris, Raises Price Target to $225
10 May 24
Needham Reiterates Hold on Steris
10 May 24
Press releases
STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024
23 Jul 24
PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP
3 Jun 24
STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year
8 May 24
STERIS Announces Dividend of $0.52 per share
1 May 24